Leqembi: US OKs monthly maintenance dosing for Alzheimer’s drug
The US Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and… Read More
The US Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and… Read More
The European Union's drugs regulator has rejected Eisai and Biogen's Leqembi treatment for early Alzheimer's… Read More
Eisai and Biogen have launched their Alzheimer's treatment Leqembi in China, the third country after… Read More
Eisai and Biogen said on Tuesday that their Alzheimer's treatment Leqembi had won approval in… Read More
Japan's Eisai said on Monday the country's health ministry had approved its Alzheimer treatment Leqembi,… Read More
A Japanese health ministry panel on Monday recommended approval of the Alzheimer's disease treatment Leqembi,… Read More
Eisai and Biogen's Leqembi won a coveted standard approval nod from the U.S. Food and… Read More